The global market for Digital Therapeutics (DTx) is projected to reach US$1.0 billion by 2025 driven by strong adoption of digital platforms like smartphones, apps, electronic wearables, mobile internet; growing focus on value based care; and rising venture capital investments in digital health based business models. DTx involves the use of online technology platforms such as mHealth tools; medical sensors; electronic medical wearables; artificial intelligence (IT); telehealth & wireless communication platforms; smartphones, apps and mobile internet, to offer medical care. The goal of DTx is to induce behavioral and lifestyle changes that positively influence disease treatment outcomes. Benefits of digital therapeutics driving its importance in the healthcare industry include the promise of overcoming the limitation of current primary care by providing timely and proactive care, reducing the risk of disease progression and lowering the burden on emergency care; enables continuous remote patient monitoring; provides social support and guidance; enables implementation of preventive healthcare; ensures patient empowerment as it encourages treatment plans based on self-reported data like diet and other lifestyle factors; greater accountability of care givers; continued support in between doctor visits; and improved treatment outcome. Healthcare reforms and the ensuing migration to value based care will provide the Launchpad for increased acceptance, adoption and proliferation of DTx, as the technology has the potential to reduce healthcare costs while simultaneously increase efficiency. Read More…

Comments

Popular posts from this blog

The Global Market for Big Data Technologies and Services is Projected to Reach $60 Billion by 2022

The Global Market for Surfing is Projected to Reach US$9.5 Billion by 2022

The Global Market for Private Tutoring Services is Forecast to Reach US$227 Billion by 2022